SVS Ventures Limited

Real Estate — Real Estate - Development · BSE

₹6.00+₹0.11 (+1.87%)

DalalBaazaar Score

55 / 100

🟡 Moderate

Verdict

CAUTION

Risk

Moderate

Driven by negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:46 pm

Understanding the Business

Company site ↗

The 60-second version of SVS Ventures Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

SVS Ventures Limited engages in the real estate and construction business in India. The company constructs and develops commercial and residential projects. It is also involved in leasing properties and consultancy services.

IndustryReal Estate - Development

SectorReal Estate

Employees2

Annual revenue₹17 Cr

How does it make money?

Turns over ₹17 Cr a year. Of every ₹100 of sales, about ₹6 reaches shareholders as profit, with ₹9 left at the operating level before interest, tax and depreciation. Each of its 2 employees supports ₹8.41 Cr of revenue a year, the signature of a capital- or asset-led business.

Revenue / employee₹8.41 Cr

Who are its competitors?

The closest listed comparisons in its industry are DLF LIMITED, GODREJ PROPERTIES LTD, OBEROI REALTY LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Little sign of one

Returns on capital of 4.2% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

Peer median ROE10.3%

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +154% while net margin moved -42% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+154%

Margin effect-42%

DalalBaazaar Score

55/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ ROCE of 4.2% is below 10% — capital is not working hard
• ROCE has been broadly stable
✗ EBITDA margin of 8.5% is thin — little cushion if costs rise
✗ Net margin of 5.9% is slim
• Revenue has compounded at 36.4% a year, which is the base these returns are earned on

Quality vs. Valuation

Company Quality

50/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

84/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

12.5x

3Y Median

226.7x

40 monthly readings · mean 200.4x · range 22.0x–485.2x

Sector Median

30.2x

median of 3 sector peers

🟢Current valuation is approximately 94% below its 3y median of 226.7x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 59% below the peer median of 30.2x.

vs. its own history

Cheap

226.7x median over 40 months · -94%

vs. sector peers

Cheap

30.2x median of 3 peers · -59%

vs. generic bands

Cheap

Below 15x

EV/EBITDA

8.9x

PEG

0.93

What's Good / What's Bad

🟢 What's Going Well1

Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

3 items require attention · 2 high · 1 watch

🔴Profit up while operating cash flow fallsFinancial
Reported profit rose but cash generated by operations declined — worth checking whether earnings are being supported by non-cash items or working capital.
🔴Significant margin compressionFinancial
EBITDA margin has fallen 6.5 points, from 15.1% to 8.5%.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹2 Cr in the latest year.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 94% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 59% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 15.1% to 8.5%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
2 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 27% a year✓ 36.4% CAGR
Latest reported year was 21926.4%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 7%✓ 8.5%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹2 Cr
Profit that never becomes cash eventually stops being profit.
4ROCE stays above 8%✗ 4.2%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.
5Valuation vs its own median of 226.7x✓ 12.5x today
A re-rating above its own history needs a reason; without one it is just a higher price.

Investment Checklist

5 / 10 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

5 good · 3 neutral · 3 weak

Market Cap

₹13 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

12.5x

Cheap

Cheap against the generic band

P/B Ratio

0.37x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹0.48

Profitable

Profitable on a per-share basis

ROE

3.0%

Weak

Weak capital efficiency

ROCE

4.2%

Weak

Low return on total capital employed

Debt/Equity

Not available

No data

Source didn't return this field

Revenue Growth (YoY)

21926.4%

Healthy

Healthy top-line growth

Profit Growth (YoY)

9701.1%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹1 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

ROA

2.3%

Weak

Assets generate little profit

Operating Margin

8.1%

Average

Average margins

Net Margin

5.9%

Average

Average bottom-line conversion

Current Ratio

3.55

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.62

Defensive

Steadier than the market

52W Range Position

13%

Near low

Near its 52-week low

Technical Snapshot

SMA 20 / SMA 50

5.5 / 5.7

Bearish alignment (short < long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

53.8

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹7 Cr	₹1 Cr	₹0 Cr	₹17 Cr	+36.4%
EBITDA	₹1 Cr	₹0 Cr	₹0 Cr	₹1 Cr	+12.9%
EBITDA Margin	15.1%	10.8%	180.8%	8.5%	—
PAT (Net Profit)	₹1 Cr	₹0 Cr	₹0 Cr	₹1 Cr	+13.5%
EPS	₹0.33	₹0.04	₹0.04	—	—
ROE	2.1%	0.3%	0.2%	3.0%	—
ROCE	2.8%	0.3%	0.3%	4.2%	—
Total Debt	₹0 Cr	₹0 Cr	₹0 Cr	—	—
Free Cash Flow	-₹18 Cr	-₹3 Cr	₹1 Cr	-₹2 Cr	—

🟢 Revenue has grown at 36.4% a year over 3 years.

🟢 EBITDA has grown at 12.9% a year over 3 years.

🔴 EBITDA Margin has fallen from 15.1% to 8.5% over 3 years (-6.5 pts).

🟢 PAT (Net Profit) has grown at 13.5% a year over 3 years.

🟡 ROE has held roughly flat at 3.0% over 3 years.

🟢 ROCE has risen from 2.8% to 4.2% over 3 years (+1.3 pts).

Balance Sheet & Cash Flow — FY2026

Total Assets

₹43 Cr

Total Liabilities

₹9 Cr

Cash & Equivalents

₹0 Cr

Operating Cash Flow

-₹2 Cr

Capex

—

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

50.9%

Peer Comparison

Company	P/E	ROE
DLF LIMITED	36.6x	10.3%
GODREJ PROPERTIES LTD	30.2x	8.4%
OBEROI REALTY LIMITED	23.5x	14.7%

Recent News

1 mixed5 general

SVS Ventures Limited Approves Regularization of Appointment of Vishal Mahendrabhai Thekdi as Managing Director

marketscreener.com, 02 Oct

SVS Ventures schedules AGM for September 30, 2026

scanx.trade, 08 Sept

14 penny stocks plunge up to 55% in 2 months. Are you affected?

The Economic Times, 31 May

SVS Ventures Ltd Share Price

Business Today, 31 Jan

Tilak Ventures - 9 penny stocks crash up to 65% in 3 months. Are you affected?

The Economic Times, 01 Mar

Q4 results 2026: Canara Bank to Indian Hotels among companies to declare Q4 results today; full list here

Livemint, 11 MayResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.
1 metric couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.

DalalBaazaar Thesis

StrongValuation

MiddlingFinancial Health · Growth

WeakBusiness Quality · Profitability · Risk

Points for each in the Score ↑

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 2 high-severity red flags sit above this conclusion and should be read first.

2 of 5 tripwires tripped — Free cash flow remains positive; ROCE stays above 8% · see Key things to watch ↑